Construction of the 23,000m2 new campus has begun. One month after the groundbreaking ceremony, leadXpro is the first company to ascertain its position...

Mehr Informationen Mehr Informationen

InterAx partners with Lundbeck to identify better pharmaceutical compounds

InterAx Biotech AG, a spin-off of the Paul Scherrer Institute PSI and ETH Zurich, based at PARK INNOVAARE, is building a proprietary systems biology platform...

Mehr Informationen

Villigen – Boston – Villigen: Successful Business Trip for InterAx Biotech AG

InterAx Biotech AG participated in a “business boosting” week in Boston, USA, in June, 2016. As part of venturelab’s international program, 10 high...

Mehr Informationen

SwissUpStart Challenge accepted, SwissUpStart Challenge completed! InterAx Biotech won the first prize.

With their biosensors, pharmaceutical industry can save 100 million CHF in the development of new drugs. No wonder the newly born spin-off of the Paul...

Mehr Informationen

InterAx Biotech AG is strengthening its scientific advisory board

Scientific advisory boards set the bar for the quality of research and development performed in big pharma, medium biotech and small start-ups. Their excellence...

Mehr Informationen

InterAx Biotech has started a new collaboration

Collaborations speed up innovation. InterAx Biotech AG, a spin-off of the Paul Scherrer Institute (PSI) and ETH Zurich, based at PARK INNOVAARE, and Professor...

Mehr Informationen
Subscribe to GPCRs